Melanoma CT manifestations

Written by Yan Chun
Oncology
Updated on November 25, 2024
00:00
00:00

The CT manifestations of melanoma vary depending on the location of the tumor. Generally, melanomas that occur on the skin can appear on CT scans as mass-like lesions, and the scans can show whether there are any urgent conditions involving the surrounding nerves, blood vessels, and tissues. Some patients may only show CT imaging changes such as localized thickening of the skin. In melanomas that occur inside the skull or in the vulva, the CT mainly shows localized mass-like lesions. These lesions are typically low-density foci with poor blood supply around them, and they generally have an irregular shape.

Other Voices

doctor image
home-news-image
Written by Sun Ming Yue
Medical Oncology
37sec home-news-image

Can melanoma be detected by ultrasound?

Melanoma is a very serious disease, and if detected in its early stages, treatment should be sought promptly. If treatment is delayed, the effects of treating the disease in its advanced stages are not very good or significant. Melanoma is a type of malignant tumor that is prone to occurrence and poses a significant risk, endangering life. Generally, if melanoma is being tested, the Vacca double PAP immunoenzymatic marking method is used for detection.

doctor image
home-news-image
Written by Liu Gang
Dermatology
44sec home-news-image

Does melanoma need to be excised?

Melanoma is a type of malignant tumor, which mostly develops from common melanocytic nevi. Once diagnosed with this disease, surgical removal is necessary. After the surgery, a full-body examination is also required to check whether the tumor cells have metastasized. If there is metastasis, further radiotherapy or chemotherapy is needed. If melanocytic nevi appear on the body, it is crucial to handle them properly, ideally by using laser treatment or surgical removal when they are relatively small to prevent the later formation of melanoma. If the melanocytic nevi cause pain, itching, or oozing after scratching, it might be a precursor to malignancy, and formal treatment is necessary.

doctor image
home-news-image
Written by Sun Ming Yue
Medical Oncology
38sec home-news-image

Is amputation useful for melanoma?

Melanoma is a very terrifying disease. Once melanoma develops on the limbs, there is a tendency to favor as extensive a surgery as possible. It seems that the larger the excision, the cleaner it becomes, which helps to prevent future recurrence and metastasis. Even undergoing amputation surgery doesn’t necessarily eliminate the risk of metastasis and recurrence. Sometimes, if the margins of the excision are not beyond the range, the risk still exists. Therefore, the extent of the excision should be determined based on the patient’s condition.

doctor image
home-news-image
Written by Yan Chun
Oncology
48sec home-news-image

Is it better for melanoma to have a BRAF mutation or not to have a BRAF mutation?

Melanoma is a type of skin cancer with a very high malignancy. Before targeted drugs were available, patients with BRAF gene mutations indicated a poorer prognosis for melanoma. The mutation of the BRAF gene promotes the progression of melanoma. However, with the advancement of current clinical research, patients with melanoma having BRAF mutations have a better therapeutic effect with BRAF inhibitor targeted therapy. After adopting this targeted drug treatment, the cure rate has significantly increased, and the prognosis of patients has markedly improved. Therefore, patients with BRAF-mutated melanoma can benefit from targeted therapy.

doctor image
home-news-image
Written by Cui Fang Bo
Oncology
52sec home-news-image

The significance of melanoma genetic testing

The significance of genetic testing for melanoma patients mainly involves two aspects: first, the identification of specific driver gene mutations to guide the application of targeted drugs; second, the detection of mutations in some common genes to judge the prognosis of the disease. Regarding the target gene mutations for drug selection, the commonly used ones include mutations in C-KIT, BRAF, and M-TOR. If mutations in these target genes are found, corresponding targeted drugs can be used for treatment. These drugs are generally orally administered, have relatively good efficacy, low side effects, and are suitable for the treatment of melanoma. Additionally, some genetic tests can predict the prognosis of melanoma patients based on the presence or absence of mutations.